Milestones magazine - annual research highlights

New publication highlights 2016-2017 CCR research advances

Milestones is the Center for Cancer Research’s new annual publication that highlights some of the top cancer-research milestones CCR investigators have reached in the last year. The collection presented here merely scratches the surface of the many advances made by CCR scientists but provides a window into the broad spectrum of our activities and the ingenuity of our scientists. Read more...

New publication highlights 2016-2017 CCR research advances

Dr. Figg receives 2017 Tyler Prize for Stimulation of Research Award

Posted: Mar 24, 2017

William Figg Sr., Pharm.D., Deputy Chief of the Genitourinary Malignancies Branch, was awarded the 2017 Tyler Prize for Stimulation of Research Award by the American Pharmacists Association (APhA). The Tyler Prize recognizes an individual for encouraging research, directing research or mentoring in the pharmaceutical sciences. One of APhA’s three most prestigious awards, it is only awarded once every three years. Read more...

Dr. Figg receives 2017 Tyler Prize for Stimulation of Research Award

Steve Rosenberg featured on CBS Sunday Morning

Posted: Mar 17, 2017

CBS Sunday Morning recently featured Surgery Branch Chief Steve Rosenberg, M.D., Ph.D. in a special “Beyond Cancer” program. Dr. Rosenberg appeared in a segment on “Immunotherapy: The next frontier in cancer treatment” as the first doctor to successfully cure a patient’s cancer using her own immune system in 1984. “We’ve gotten to the point now where I think we understand why the patients who are successfully treated experience tumor regression,” Dr. Rosenberg said. “And based on that knowledge, I think we’re going to see dramatic progress in the next few years to come.”

Steve Rosenberg featured on CBS Sunday Morning

German Minister of Health and scientists tour Clinical Center

Posted: Mar 17, 2017

CCR had the privilege of welcoming a number of German dignitaries this week. The German Minister of Health, Hermann Gröhe, and the German State Secretary for Education and Research, Dr. George Schütte, toured the NIH Clinical Center on Wednesday, March 15, 2017. They spoke with Brigitte Widemann, M.D., and toured Jack Shern’s lab in the Pediatric Oncology Branch and visited Peter Choyke, M.D., F.A.C.R., in the Molecular Imaging Clinic and discussed clinical trials with Caryn Steakley, R.N., M.S.W, Deputy Clinical Dirctor. Another group of German scientists met with CCR investigators Glenn Merlino, Ph.D., Natasha Caplen, Ph.D., Tim Greten, M.D., Kevin Camphausen, M.D. and Louis Staudt, M.D., Ph.D. The group met to discuss ongoing research in the CCR and explore areas for future collaboration.

German Minister of Health and scientists tour Clinical Center

Study shows aspirin reduces the risk and recurrence of prostate cancer in African-American men

Posted: Mar 17, 2017

African-American men who take a daily dose of aspirin experience a significantly lower risk of developing advanced prostate cancer – the aggressive and deadly form of the disease – than African-American men who do not regularly use aspirin, according to a study from the Center for Cancer Research (CCR) Laboratory of Human Carcinogenesis. Learn more...

Study shows aspirin reduces the risk and recurrence of prostate cancer in African-American men

A teen’s participation in clinical trials inspires a career in science

Posted: Mar 13, 2017

Nathan Porter, a 16-year-old student with a rare disease called multiple endocrine neoplasia, discussed his experience with the condition with The Daily Times of Blount County, Tennesse, for February’s Rare Disease Day. When first diagnosed with the disease at age 10, he says he thought “Why me?” However, in eighth grade, when the condition led him to participate in clinical trials at the NIH Clinical Research Center, he discovered his passion for science and has since applied for a summer internship at NIH. “Dealing with nurses and doctors of this degree really led me to my passion in the sciences and psychology and genetics, which is what I want to go into with my life,” he says. “My main passion is genetics, and what I would like to do is look at genetic cancers, go in there and see what exactly causes them to be passed down and look at how they get turned on.”  Learn more...

A teen’s participation in clinical trials inspires a career in science

In Memoriam: Amar J.S. Klar, Ph.D.

Posted: Mar 7, 2017

The Center for Cancer Research mourns the recent death of colleague and friend Amar J.S. Klar, Ph.D.  Dr. Klar was a much-liked and respected member of the NCI community as part of the Gene Regulation and Chromosome Biology Laboratory since 1988.  Read more...

In Memoriam: Amar J.S. Klar, Ph.D.

Safety and tolerability of combination therapy vs. standard treatment alone for patients with previously treated non-small cell lung cancer

Posted: Mar 3, 2017

Dr. James Gulley is leading a team to test the safety and tolerability of the combination of nivolumab and CV301 to see if it can improve the survival for patientis with metastatic non-small cell lung cancer.  Learn more...

Safety and tolerability of combination therapy vs. standard treatment alone for patients with previously treated non-small cell lung cancer

Pages